Position in AVNS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,244,000
+$1,006,128 QoQ
Shares Held
50,000
+405.1% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#84
of 276 holders
Holding Since
Sep 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVNS Over Time
Shares Held
Position Value (USD)
Derivatives in AVNS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,244,000
PutShares
50,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $17,999,021 across 26 Medical Devices names. AVNS ranks #3 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
150,288 | $6,414,291 | |
| 2 | PEN |
Penumbra Inc
|
15,000 | $4,736,250 | |
| 3 | AVNS |
Avanos Medical, Inc.
This page
|
50,000 | $1,244,000 | |
| 4 | EW |
Edwards Lifesciences Corp
|
9,122 | $825,176 | |
| 5 | BRKR |
Bruker Corp
|
12,000 | $722,160 | |
| 6 | INMD |
InMode Ltd.
|
26,950 | $394,009 | |
| 7 | STIM |
Neuronetics, Inc.
|
285,913 | $371,686 | |
| 8 | PRCT |
PROCEPT BioRobotics Corp
|
15,562 | $351,389 |
All Filings in AVNS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,244,000 | 50,000 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $1,244,000 | 50,000 | Put | Sole | 2026-08-13 | |
| 2024-09-30 | $237,872 | 9,899 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $322,026 | 16,166 | Shares | Sole | 2024-08-14 | |
| 2021-12-31 | $267,756 | 7,723 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $208,197 | 6,673 | Shares | Sole | 2021-11-17 | |
| No filing history on record for this holder in this stock. | ||||||